CMB 2.50% 41.0¢ cambium bio limited

...mgmt may be "working hard" to close SP and asset value gap,...

  1. 163 Posts.
    lightbulb Created with Sketch. 3
    ...mgmt may be "working hard" to close SP and asset value gap, but failing at it for past 12 mos...or mkt sees little fundamental assets value under current mgmt

    Edison spruiked $100 mil valuation from 2 rgs anncs by year end. Report savaged as wild optimistic coy advert to "mushroom shareholders" w/ rgs treating SHers as "morons". rgs need solid demonstration they are not a marginally capitalised coy w/ ongoing product development utterly dependent on an under-performing management team raising onward financing for a "fairly baseless product pipeline".

    I'm not that dirty on rgs pipeline but they have now built critical mkt expectation...& mgmt performance last 12 mos a shocker. Important coy show strong solid commercialisation/partnership performance w/in next 4 wks....& comms. If "2 anncs." more of same R&D/IP/CT-progress to Jan or vague partnerships re sales & revenue....look out below. Time for coy to lift game (& SP) & demonstrate fundamentals. Mkt waiting, SHers hoping, clock ticking
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.